Veeva Systems (NYSE:VEEV – Get Free Report) updated its FY 2027 earnings guidance on Wednesday. The company provided earnings per share guidance of 9.210-9.210 for the period, compared to the consensus estimate of 8.580. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $3.6 billion. Veeva Systems also updated its Q3 2027 guidance to 2.330-2.340 EPS.
Veeva Systems Price Performance
Shares of VEEV stock opened at $282.76 on Friday. Veeva Systems has a 1-year low of $148.05 and a 1-year high of $310.50. The stock’s 50-day moving average is $206.00 and its 200 day moving average is $183.73. The company has a market cap of $45.93 billion, a P/E ratio of 46.51, a PEG ratio of 1.05 and a beta of 0.92.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its earnings results on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $0.12. The business had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.37%. The firm’s revenue was up 17.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, analysts anticipate that Veeva Systems will post 6.65 EPS for the current year.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on VEEV
Insider Buying and Selling
In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the business’s stock in a transaction that occurred on Thursday, August 13th. The shares were sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the sale, the insider owned 19,449 shares of the company’s stock, valued at approximately $4,866,723.27. The trade was a 64.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by company insiders.
Trending Headlines about Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Quarterly results exceeded expectations: Fiscal Q2 revenue rose 17.6% year over year to $928.0 million, topping the $905.4 million consensus estimate. Non-GAAP EPS of $2.35 also beat expectations of approximately $2.22-$2.23 and increased from $1.99 a year earlier. Veeva Announces Fiscal 2027 Second Quarter Results
- Positive Sentiment: Raised guidance provided an additional catalyst: Veeva forecast third-quarter revenue of $932 million-$935 million and EPS of $2.33-$2.34, above analyst estimates of $917.9 million and $2.16, respectively. Full-year fiscal 2027 EPS guidance of $9.21 and revenue guidance of roughly $3.7 billion also exceeded consensus expectations. Veeva Systems Q2 Earnings and Revenues Beat Estimates
- Positive Sentiment: CRM and AI momentum strengthened the growth narrative: Management highlighted record Vault CRM execution, continued commercial-cloud adoption and rising demand for its Falcon AI offering, with initial Falcon customer deployments expected this year. VEEV Q2 Earnings Call Centers on Falcon and CRM Momentum
- Positive Sentiment: Analysts broadly raised price targets: Barclays, RBC, Guggenheim, Truist and Robert W. Baird increased their targets, with RBC moving to $325 and Barclays to $315; several maintained positive ratings. RBC Raises Veeva Price Target
- Neutral Sentiment: Analyst reaction was not uniformly bullish: UBS and Morgan Stanley retained neutral or equal-weight ratings, while Canaccord maintained a hold rating despite raising its target.
- Negative Sentiment: Several revised targets remain below the current trading level, including BMO’s $270, Canaccord’s $260 and Morgan Stanley’s $275, signaling valuation concerns after the rally.
Institutional Investors Weigh In On Veeva Systems
A number of large investors have recently made changes to their positions in VEEV. Williams Jones Wealth Management LLC. raised its stake in Veeva Systems by 0.4% in the 3rd quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company’s stock worth $2,806,000 after acquiring an additional 40 shares during the last quarter. Rafferty Asset Management LLC increased its holdings in shares of Veeva Systems by 0.7% in the second quarter. Rafferty Asset Management LLC now owns 6,881 shares of the technology company’s stock valued at $1,982,000 after purchasing an additional 51 shares during the period. Brown Brothers Harriman & Co. increased its holdings in shares of Veeva Systems by 8.1% in the third quarter. Brown Brothers Harriman & Co. now owns 719 shares of the technology company’s stock valued at $214,000 after purchasing an additional 54 shares during the period. Raiffeisen Bank International AG boosted its position in Veeva Systems by 59.8% in the fourth quarter. Raiffeisen Bank International AG now owns 155 shares of the technology company’s stock valued at $35,000 after buying an additional 58 shares during the last quarter. Finally, Rakuten Securities Inc. increased its holdings in Veeva Systems by 56.7% in the 2nd quarter. Rakuten Securities Inc. now owns 163 shares of the technology company’s stock worth $47,000 after buying an additional 59 shares during the period. 88.20% of the stock is owned by hedge funds and other institutional investors.
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Read More
- Five stocks we like better than Veeva Systems
- Could Falling Yields Make REIT Stocks Worth a Second Look?
- CrowdStrike’s “Mythos Moment” Tests the Bigger AI Security Trade
- 3 Stocks Facing New Pressure From Section 338 Tariffs on Canadian Goods
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
